Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels
Catherine Euvrard(Centre hospitalier de l'Université Laval), Jacques R. Boissier(Centre hospitalier de l'Université Laval), Claude Oberlander(Centre hospitalier de l'Université Laval), Thérèse Di Paolo(Université Laval), Jean‐Pierre Raynaud(Centre hospitalier de l'Université Laval), Louise Ferland(Centre hospitalier de l'Université Laval), Fernand Labrie(Endocyte (United States)), Jean‐Martin Beaulieu(University of Toronto)
Cited by 122
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
|Cell|2005|966
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
|Proceedings of the National Academy of Sciences|2004|786
Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis
|Science|2004|685
Characterization of polysaccharides extracted from brown seaweeds
|Carbohydrate Polymers|2007|590